Related Experiment Videos
Hormone replacement therapy after surgery for stage 1 or 2 cutaneous melanoma
1Public Health and Health Policy University of Glasgow, Glasgow G12 8RZ, UK. R.M.Mackie@clinmed.gla.ac.uk
British Journal of Cancer
|February 19, 2004
Abstract:
A total of 206 women were followed for a minimum of 5 years after primary melanoma surgery to establish if hormone replacement therapy (HRT) adversely affected prognosis. In all, 123 had no HRT and 22 have died of melanoma; 83 had HRT for varying periods and one has died of melanoma. After controlling for known prognostic factors, we conclude that HRT after melanoma does not adversely affect prognosis.